logo

ARMK

Aramark·NYSE
--
--(--)
--
--(--)
6.55 / 10
Outperform

ARMK demonstrates good fundamental health, scoring 6.5/10. Key positives include strong year-over-year growth in earnings per share (24% basic, 23.2% diluted), profit (18%), and cash flow from operations (26.8%). Ratios such as PB-ROE (-0.31) and Asset-MV (-0.50) place the company in favorable quartiles, supporting an optimistic fundamental stance. However, the Interest Coverage ratio of 2.26 is only moderate, indicating some leverage concern.

Fundamental(6.55)SentimentTechnical

Analysis Checks(10/10)

Revenue-MV
Value1.63
Score3/3
Weight8.43%
1M Return3.16%
PB-ROE
Value-0.31
Score3/3
Weight12.12%
1M Return5.33%
Basic earnings per share (YoY growth rate %)
Value24.00
Score3/3
Weight11.88%
1M Return4.41%
Total profit (YoY growth rate %)
Value17.98
Score3/3
Weight13.37%
1M Return4.83%
Net cash flow from operating activities (YoY growth rate %)
Value26.77
Score2/3
Weight8.27%
1M Return3.31%
Interest coverage ratio (EBIT / Interest expense) (%)
Value2.26
Score2/3
Weight4.88%
1M Return1.98%
Diluted earnings per share (YoY growth rate %)
Value23.23
Score3/3
Weight12.40%
1M Return4.57%
Asset-MV
Value-0.50
Score2/3
Weight8.22%
1M Return3.55%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value24.33
Score3/3
Weight13.25%
1M Return4.86%
Cash-MV
Value1.67
Score2/3
Weight7.19%
1M Return3.23%
Is ARMK undervalued or overvalued?
  • ARMK scores 6.55/10 on fundamentals and holds a Discounted valuation at present. Backed by its 10.51% ROE, 1.77% net margin, 31.18 P/E ratio, 3.22 P/B ratio, and 24.00% earnings growth, these metrics solidify its Outperform investment rating.